Cargando…

Protease Addiction and Synthetic Lethality in Cancer

The “oncogene addiction” concept refers to the dependence of cancer cells on the function of the oncogenes responsible for their transformed phenotype, while the term “non-oncogene addiction” has been introduced to define the exacerbated necessity of the normal function of non-mutated genes. In this...

Descripción completa

Detalles Bibliográficos
Autores principales: Freije, José M. P., Fraile, Julia M., López-Otín, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Research Foundation 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356009/
https://www.ncbi.nlm.nih.gov/pubmed/22655236
http://dx.doi.org/10.3389/fonc.2011.00025
_version_ 1782233479450198016
author Freije, José M. P.
Fraile, Julia M.
López-Otín, Carlos
author_facet Freije, José M. P.
Fraile, Julia M.
López-Otín, Carlos
author_sort Freije, José M. P.
collection PubMed
description The “oncogene addiction” concept refers to the dependence of cancer cells on the function of the oncogenes responsible for their transformed phenotype, while the term “non-oncogene addiction” has been introduced to define the exacerbated necessity of the normal function of non-mutated genes. In this Perspective, we focus on the importance of proteolytic enzymes to maintain the viability of cancer cells and hypothesize that most, if not all, tumors present “addiction” to a number of proteolytic activities, which in turn may represent valuable targets of anti-cancer therapies, even without being mutated or over-expressed by the malignant cells.
format Online
Article
Text
id pubmed-3356009
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Frontiers Research Foundation
record_format MEDLINE/PubMed
spelling pubmed-33560092012-05-31 Protease Addiction and Synthetic Lethality in Cancer Freije, José M. P. Fraile, Julia M. López-Otín, Carlos Front Oncol Oncology The “oncogene addiction” concept refers to the dependence of cancer cells on the function of the oncogenes responsible for their transformed phenotype, while the term “non-oncogene addiction” has been introduced to define the exacerbated necessity of the normal function of non-mutated genes. In this Perspective, we focus on the importance of proteolytic enzymes to maintain the viability of cancer cells and hypothesize that most, if not all, tumors present “addiction” to a number of proteolytic activities, which in turn may represent valuable targets of anti-cancer therapies, even without being mutated or over-expressed by the malignant cells. Frontiers Research Foundation 2011-09-05 /pmc/articles/PMC3356009/ /pubmed/22655236 http://dx.doi.org/10.3389/fonc.2011.00025 Text en Copyright © 2011 Freije, Fraile and López-Otín. http://www.frontiersin.org/licenseagreement This is an open-access article subject to a non-exclusive license between the authors and Frontiers Media SA, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and other Frontiers conditions are complied with.
spellingShingle Oncology
Freije, José M. P.
Fraile, Julia M.
López-Otín, Carlos
Protease Addiction and Synthetic Lethality in Cancer
title Protease Addiction and Synthetic Lethality in Cancer
title_full Protease Addiction and Synthetic Lethality in Cancer
title_fullStr Protease Addiction and Synthetic Lethality in Cancer
title_full_unstemmed Protease Addiction and Synthetic Lethality in Cancer
title_short Protease Addiction and Synthetic Lethality in Cancer
title_sort protease addiction and synthetic lethality in cancer
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356009/
https://www.ncbi.nlm.nih.gov/pubmed/22655236
http://dx.doi.org/10.3389/fonc.2011.00025
work_keys_str_mv AT freijejosemp proteaseaddictionandsyntheticlethalityincancer
AT frailejuliam proteaseaddictionandsyntheticlethalityincancer
AT lopezotincarlos proteaseaddictionandsyntheticlethalityincancer